Cited by 709Diet, Metabolism, and DiseaseLiver Disease Diagnosis and TreatmentLipid metabolism and biosynthesis

The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease

Open access

Softic, Samir, Cohen, David E., Kahn, C. Ronald·2016·Digestive Diseases and Sciences

DOI 10.1007/s10620-016-4054-0PMC PMC4838515

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome. Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD. Today the most commonly consumed sugar is high fructose corn syrup. Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL). A central abnormality in NAFLD is enhanced DNL. Hepatic DNL is increased in individuals with NAFLD, while the contribution of dietary fat and plasma FFA to hepatic lipids is not significantly altered. The importance of DNL in NAFLD is further established in mouse studies with knockout of genes involved in this process. Dietary fructose increases levels of enzymes involved in DNL even more strongly than HFD. Several properties of fructose metabolism make it particularly lipogenic. Fructose is absorbed via portal vein and delivered to the liver in much higher concentrations as compared to other tissues. Fructose increases protein levels of all DNL enzymes during its conversion into triglycerides. Additionally, fructose supports lipogenesis in the setting of insulin resistance as fructose does not require insulin for its metabolism, and it directly stimulates SREBP1c, a major transcriptional regulator of DNL. Fructose also leads to ATP depletion and suppression of mitochondrial fatty acid oxidation, resulting in increased production of reactive oxygen species. Furthermore, fructose promotes ER stress and uric acid formation, additional insulin independent pathways leading to DNL. In summary, fructose metabolism supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD. Disrupting fructose metabolism in the liver may provide a new therapeutic option for the treatment of NAFLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s10620-016-4054-0

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
Sontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Self-citation
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
The global NAFLD epidemic
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732
Insulin Receptor Signaling in Normal and Insulin-Resistant StatesPreprint
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,550
Self-citation

Flagged first, then by citations

Show all 133 references

1 of the 133 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 705

Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation
Helsley, R. N., Park, S., Vekaria, H. J., Sullivan, P. G., Conroy, L. R., Sun, R. C., Romero, M. D. M., Herrero, L., Bons, J., King, C. D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.010 · Cited by 57
Self-citation
The role of hepatic lipid composition in obesity‐related metabolic disease
Willis, S. A., Bawden, S., Malaikah, S., Sargeant, J. A., Stensel, D. J., Aithal, G. P., & King, J. A. (2021) · Liver International · doi:10.1111/liv.15059 · Cited by 63
Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 59
Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD - an umbrella overview of systematic review of meta-analysis
Xiao, J., Ng, C. H., Chan, K. E., Fu, C., Tay, P., Yong, J. N., Lim, W. H., Tan, D. J. H., Syn, N., Wong, Z. Y., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.006 · Cited by 56
Selenium and selenoprotein P in nonalcoholic fatty liver disease
Pοlyzos, S. A., Kountouras, J., Goulas, A., & Duntas, L. H. (2019) · HORMONES · doi:10.1007/s42000-019-00127-3 · Cited by 54
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review
Yarahmadi, A., Afkhami, H., Javadi, A., & Kashfi, M. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01561-z · Cited by 61
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)
Huard, K., Ahn, K., Amor, P. A., Beebe, D. A., Borzilleri, K. A., Chrunyk, B. A., Coffey, S. B., Cong, Y., Conn, E. L., Culp, J. S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00947 · Cited by 55
A comparative genomics study of carbohydrate/glucose metabolic genes: from fish to mammals
Zhang, Y., Qin, C., Yang, L., Lu, R., Zhao, X., & Nie, G. (2018) · BMC Genomics · doi:10.1186/s12864-018-4647-4 · Cited by 55
HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP
Lane, E. A., Choi, D. W., García-Haro, L., Levine, Z. G., Tedoldi, M., Walker, S., & Danial, N. N. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.019 · Cited by 57
Lactobacillus plantarum KFY04 prevents obesity in mice through the PPAR pathway and alleviates oxidative damage and inflammation
Long, X., Zeng, X., Tan, F., Yi, R., Pan, Y., Zhou, X., Mu, J., & Zhao, X. (2020) · Food & Function · doi:10.1039/d0fo00519c · Cited by 50
Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis
Oh, S., Son, M., Byun, K.-A., Jang, J. T., Choi, C. H., Son, K. H., & Byun, K. (2021) · Marine Drugs · doi:10.3390/md19060318 · Cited by 52
Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications
Kwon, D., Kim, S., & Correia, M. A. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.002 · Cited by 53
Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
Paik, J. M., Mir, S., Alqahtani, S. A., Younossi, Y., Ong, J. P., & Younossi, Z. M. (2021) · Hepatology Communications · doi:10.1002/hep4.1707 · Cited by 50
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Gupta, H., Min, B.-H., Ganesan, R., Gebru, Y. A., Sharma, S. P., Park, E., Won, S., Jeong, J., Lee, S.-B., Cha, M., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030550 · Cited by 50
Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity
Zhang, S., Guo, F., Yu, M., Yang, X., Yao, Z., Li, Q., Wei, Z., Feng, K., Zeng, P., Zhao, D., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.034 · Cited by 49
Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model
Saha, M., Manna, K., & Saha, K. D. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s343236 · Cited by 48
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
Ma, N., Wang, Y., Xu, S., Ni, Q., Zheng, Q., Zhu, B., Cao, H., Jiang, H., Zhang, F.-K., Yuan, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23285-8 · Cited by 48
Vegetarian diet, food substitution, and nonalcoholic fatty liver
Lin, C., Chiu, T. H. T., Lin, M., Pan, W.-H., & Chen, Y. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_109_17 · Cited by 47
Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice
Shin, M., Yang, S.-M., & Han, I. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1810771 · Cited by 47
Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD
Sun, Q., Niu, Q., Guo, Y., Zhuang, Y., Li, X., Liu, J., Li, N., Li, Z., Huang, F., & Qiu, Z. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03105 · Cited by 46
Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes
Steinbrenner, H., Micoogullari, M., Hoang, N. A., Bergheim, I., Klotz, L., & Sies, H. (2018) · Redox Biology · doi:10.1016/j.redox.2018.11.004 · Cited by 44
Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Lombardi, R., Iuculano, F., Pallini, G., Fargion, S. R., & Fracanzani, A. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228761 · Cited by 47
Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway
Reda, D., Elshopakey, G. E., Albukhari, T. A., Almehmadi, S. J., Refaat, B., Risha, E., Mahgoub, H. A., El‐Boshy, M., & Abdelhamid, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1164512 · Cited by 45
Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice
Zhao, C., Liu, L., Liu, Q., Li, F., Zhang, L., Zhu, F., Shao, T., Barve, S. S., Chen, Y., Li, X., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.020 · Cited by 47
Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats
Arellano-García, L., Trepiana, J., Martínez, J. A., Portillo, M. P., & Milton‐Laskibar, I. (2023) · Antioxidants · doi:10.3390/antiox12030717 · Cited by 45
Consenso mexicano de la enfermedad por hígado graso no alcohólico
Bernal-Reyes, R., Castro‐Narro, G., Malé-Velázquez, R., Carmona-Sánchez, R., González-Huezo, M. S., García-Juárez, I., Chávez-Tapia, N. C., Aguilar-Salinas, C., Aiza-Haddad, I., Ballesteros-Amozurrutia, M. A., et al. (2019) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2018.11.007 · Cited by 52
High fructose intake and the route towards cardiometabolic diseases
Lelis, D. D. F., Andrade, J. M. O., Almenara, C. C. P., Broseghini-Filho, G. B., Mill, J. G., & Baldo, M. P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118235 · Cited by 46
Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
Zhang, Z., Ji, G., & Li, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1247611 · Cited by 46
Exercise training modulates the hepatic renin–angiotensin system in fructose‐fed rats
Frantz, E. D. C., Medeiros, R. F., Giori, I. G., Lima, J. B. S., Bento‐Bernardes, T., Gaique, T. G., Fernandes‐Santos, C., Fernandes, T., de Oliveira, E. M., Vieira, C. P., et al. (2017) · Experimental Physiology · doi:10.1113/ep085924 · Cited by 43
Prediabetes Induced by Fructose-Enriched Diet Influences Cardiac Lipidome and Proteome and Leads to Deterioration of Cardiac Function prior to the Development of Excessive Oxidative Stress and Cell Damage
Szűcs, G., Sója, A., Péter, M., Sárközy, M., Bruszel, B., Siska, A., Földesi, I., Szabó, Z., Janáky, T., Vı́gh, L., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3218275 · Cited by 43
Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
Yao, Z., Gong, Y., Chen, W., Shao, S., Song, Y., Guo, H., Li, Q., Liu, S., Wang, X., Zhang, Z., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00896-7 · Cited by 48
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
Golabi, P., Owrangi, S., & Younossi, Z. M. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17833 · Cited by 45
Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver disease
Baselga‐Escudero, L., Souza‐Mello, V., Pascual‐Serrano, A., Rachid, T. L., Voci, A., Demori, I., & Grasselli, E. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.11.019 · Cited by 42
Psoriasis e hígado graso no alcohólico
Carrascosa, J. M., Bonanad, C., Daudén, E., Botella, R., & Olveira-Martín, A. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2016.12.017 · Cited by 45
MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1
Zhang, M., Tang, Y., Tang, E., & Lu, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.143 · Cited by 42
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Kosmalski, M., Śliwińska, A., & Drzewoski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11041097 · Cited by 44
Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models
Matsukawa, T., Yagi, T., Uchida, T., Sakai, M., Mitsushima, M., Naganuma, T., Yano, H., Inaba, Y., Inoue, H., Yanagida, K., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.161282 · Cited by 43
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Termite, F., Archilei, S., D’Ambrosio, F., Petrucci, L., Viceconti, N., Iaccarino, R., Liguori, A., Gasbarrini, A., & Miele, L. (2025) · Antioxidants · doi:10.3390/antiox14010056 · Cited by 50
Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model
Briand, F., Brousseau, E., Quinsat, M., Burcelin, R., & Sulpice, T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.021 · Cited by 41
Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans
Beysen, C., Ruddy, M. K., Stoch, A., Mixson, L. A., Rosko, K., Riiff, T. J., Turner, S., Hellerstein, M. K., & Murphy, E. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00470.2017 · Cited by 41
Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism
Vazquez-Borrego, M. C., del Río-Moreno, M., & Kineman, R. D. (2021) · Cells · doi:10.3390/cells10102532 · Cited by 39
Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study
de Oliveira, D. G., Ghetti, F. D. F., Moreira, A. P. B., Hermsdorff, H. H. M., de Oliveira, J. M., & Ferreira, L. E. V. V. D. C. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1776-0 · Cited by 40
In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions
Zhu, Z., Zhang, X., Pan, Q., Zhang, L., & Chai, J. (2023) · Liver Research · doi:10.1016/j.livres.2023.11.003 · Cited by 38
Danggui-Shaoyao-San Improves Gut Microbia Dysbiosis and Hepatic Lipid Homeostasis in Fructose-Fed Rats
Yin, J., Lu, J., Peng, L., He, M., Huang, S., Lv, J., Zhu, Y., Liu, Z., & Jiang, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671708 · Cited by 39
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
Karin, M., & Kim, J. Y. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13685 · Cited by 45
Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats
Li, Y., Wang, C., Jin, Y., Chen, H., Cao, M., Li, W., Luo, H., & Wu, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109734 · Cited by 40
Oil and extract of safflower seed improve fructose induced metabolic syndrome through modulating the homeostasis of trace elements, TNF-α and fatty acids metabolism
Nimrouzi, M., Ruyvaran, M., Zamani, A., Nasiri, K., & Akbari, A. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112721 · Cited by 38
Thyme oxymel by improving of inflammation, oxidative stress, dyslipidemia and homeostasis of some trace elements ameliorates obesity induced by high-fructose/fat diet in male rat
Nimrouzi, M., Abolghasemi, J., Sharifi, M. H., Nasiri, K., & Akbari, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110079 · Cited by 38
A new preclinical model of western diet‐induced progression of non‐alcoholic steatohepatitis to hepatocellular carcinoma
Green, C. D., Weigel, C., Brown, R. D. R., Bédossa, P., Dozmorov, M. G., Sanyal, A. J., & Spiegel, S. (2022) · The FASEB Journal · doi:10.1096/fj.202200346r · Cited by 38
Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome
Cannizzaro, L., Rossoni, G., Savi, F., Altomare, A., Marinello, C., Saethang, T., Carini, M., Payne, D. M., Pisitkun, T., Aldini, G., et al. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-016-0149-z · Cited by 38
Arterial Stiffness, Sugar-Sweetened Beverages and Fruits Intake in a Rural Population Sample: Data from the Brisighella Heart Study
Cicero, A. F. G., Fogacci, F., Desideri, G., Grandi, E., Rizzoli, E., D’Addato, S., & Borghi, C. (2019) · Nutrients · doi:10.3390/nu11112674 · Cited by 37
Gallic acid impairs fructose-driven de novo lipogenesis and ameliorates hepatic steatosis via AMPK-dependent suppression of SREBP-1/ACC/FASN cascade
Lu, Y., Zhang, C., Song, Y., Chen, L., Chen, X., Zheng, G., Yang, Y., Cao, P., & Qiu, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175457 · Cited by 38
The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
Park, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 37
Synthesis of Fructose Biosensors and Progressing Their Efficiency Using Californium Colloidal Nanoparticles for Detecting Fructose and Triglycerides
Heidari, A. (2020) · Advanced Science Engineering and Medicine · doi:10.1166/asem.2020.2635 · Cited by 36
Current challenges and future implications of exploiting the omics data into nutrigenetics and nutrigenomics for personalized diagnosis and nutrition-based care
Singh, V. M. (2023) · Nutrition · doi:10.1016/j.nut.2023.112002 · Cited by 41
LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway
Xu, S., Wang, Y., Li, Z., Hua, Q., Jiang, M., & Fan, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889858 · Cited by 38
Fructose Induced KHK-C Increases ER Stress and Modulates Hepatic Transcriptome to Drive Liver Disease in Diet-Induced and Genetic Models of NAFLD
Park, S., Helsley, R. N., Fadhul, T., Willoughby, J. L. S., Noetzli, L. J., Tu, H.-C., Solheim, M. H., Fujisaka, S., Pan, H., Dreyfuss, J. M., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155591 · Cited by 37
Self-citation
Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects
Jiang, N., Li, W., Jiang, S., Xie, M., & Liu, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115519 · Cited by 38
Diets High in Fat or Fructose Differentially Modulate Bone Health and Lipid Metabolism
Jatkar, A., Kurland, I. J., & Judex, S. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0205-8 · Cited by 35
The Mexican consensus on nonalcoholic fatty liver disease
Bernal-Reyes, R., Castro‐Narro, G., Malé-Velázquez, R., Carmona-Sánchez, R., González-Huezo, M. S., García-Juárez, I., Chávez-Tapia, N. C., Aguilar-Salinas, C., Aiza-Haddad, I., Ballesteros-Amozurrutia, M. A., et al. (2019) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2019.02.003 · Cited by 35
Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model
Gamede, M. W., Mabuza, L. P., Ngubane, P. S., & Khathi, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s218626 · Cited by 35
Fructose and metabolic health: governed by hepatic glycogen status?
Hengist, A., Koumanov, F., & Gonzalez, J. T. (2019) · The Journal of Physiology · doi:10.1113/jp277767 · Cited by 36
Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis
Jung, S., Bae, H., Song, W., Chun, Y., Le, J., Alam, Y. H., Verlande, A., Chun, S. K., Kim, J., Kelly, M. E., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01356-0 · Cited by 38
Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice
Ohashi, T., Kato, M., Yamasaki, A., Kuwano, A., Suzuki, H., Kohjima, M., & Ogawa, Y. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.05.006 · Cited by 34
Sesamol intervention ameliorates obesity-associated metabolic disorders by regulating hepatic lipid metabolism in high-fat diet-induced obese mice
Qin, H., Xu, H., Yu, L., Yang, L., Lin, C., & Chen, J. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.3637 · Cited by 34
Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults
Sigala, D. M., Hieronimus, B., Medici, V., Lee, V., Nuñez, M. V., Bremer, A. A., Cox, C. L., Price, C. A., Benyam, Y., Chaudhari, A. J., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab508 · Cited by 37
Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease
Huh, J. Y., & Saltiel, A. R. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00712-w · Cited by 39
Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models
Arellano-García, L., Portillo, M. P., Martínez, J. A., & Milton‐Laskibar, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063167 · Cited by 37
Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice
Desjardins, E. M., Wu, J., Lavoie, D. C. T., Ahmadi, E., Townsend, L. K., Morrow, M. R., Wang, D., Tsakiridis, E. E., Batchuluun, B., Fayyazi, R., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101193 · Cited by 33
Association between ultra-processed foods consumption and risk of non-alcoholic fatty liver disease: a population-based analysis of NHANES 2011-2018
Liu, Z., Huang, H., Zeng, Y., Chen, Y., & Xu, C. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114522003956 · Cited by 32
Circadian rhythm–dependent induction of hepatic lipogenic gene expression in rats fed a high-sucrose diet
Sun, S., Hanzawa, F., Kim, D., Umeki, M., Nakajima, S., Sakai, K., Ikeda, S., Mochizuki, S., & Oda, H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010328 · Cited by 34
Dietary fructose and dyslipidemia: new mechanisms involving apolipoprotein CIII
Hieronimus, B., & Stanhope, K. L. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000653 · Cited by 33
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Harris, S., Poolman, T. M., Arvaniti, A., Cox, R., Gathercole, L., & Tomlinson, J. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2020 · Cited by 35
Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset
Milton‐Laskibar, I., Marcos-Zambrano, L. J., Gómez‐Zorita, S., Fernández‐Quintela, A., Pau, E. C. D. S., Martínez, J. A., & Portillo, M. P. (2021) · Nutrients · doi:10.3390/nu13051738 · Cited by 33
Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase
Elseweidy, M. M., Elesawy, A. E., Sobh, M. S., & Elnagar, G. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120751 · Cited by 33
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Kim, H.-J., Park, C., & Kim, T. H. (2023) · Cells · doi:10.3390/cells12091292 · Cited by 34
Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial
Khodami, B., Hatami, B., Yari, Z., Alavian, S. M., Sadeghi, A., Kord‐Varkaneh, H., Santos, H. O., & Hekmatdoost, A. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01081-x · Cited by 32
Chronic consumption of the dietary polyphenol chrysin attenuates metabolic disease in fructose-fed rats
Andrade, N., Andrade, S., Silva, C., Rodrigues, I., Guardão, L., Guimarães, J. T., Keating, E., & Martel, F. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01895-9 · Cited by 31
18α-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation
Cheng, X., Qiu, L., & Wang, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109702 · Cited by 31
Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages
Liu, H., Niu, Q., Wang, T., Dong, H., & Bian, C. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57610 · Cited by 32
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma
Zhou, Y., Tao, J., Calvisi, D. F., & Chen, X. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731709 · Cited by 30
The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices
Prins, G. H., Ríos-Morales, M., Gerding, A., Reijngoud, D., Olinga, P., & Bakker, B. M. (2021) · Nutrients · doi:10.3390/nu13124203 · Cited by 30
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Vidal‐Cevallos, P., Sorroza-Martínez, A. P., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084397 · Cited by 32
Hepatocyte programmed cell death: the trigger for inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
Cheng, Z., Chu, H., Seki, E., Lin, R., & Yang, L. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1431921 · Cited by 31
Habitual Fructose Intake Relates to Insulin Sensitivity and Fatty Liver Index in Recent-Onset Type 2 Diabetes Patients and Individuals without Diabetes
Weber, K. S., Simon, M., Straßburger, K., Markgraf, D. F., Buyken, A. E., Szendroedi, J., Müssig, K., Roden, M., & GDS Group (2018) · Nutrients · doi:10.3390/nu10060774 · Cited by 31
Gegen Qinlian Decoction Attenuates High‐Fat Diet‐Induced Steatohepatitis in Rats via Gut Microbiota
Guo, Y., Ding, P., Liu, L., Shi, L., Mao, T., Li, J., & Wang, Y.-L. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7370891 · Cited by 30
Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome
Erkin‐Cakmak, A., Bains, Y., Caccavello, R. J., Noworolski, S. M., Schwarz, J., Mulligan, K. M., Lustig, R. H., & Gugliucci, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02772 · Cited by 30
Exhaustive Training Leads to Hepatic Fat Accumulation
da Rocha, A. L., Pinto, A. P., Teixeira, G. R., Pereira, B. C., Oliveira, L. C., Caldo‐Silva, A., Morais, G. P., Cintra, D. E., Pauli, J. R., & da Silva, A. S. R. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25625 · Cited by 29
A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices
Prins, G. H., Luangmonkong, T., Oosterhuis, D., Mutsaers, H. A. M., Dekker, F. J., & Olinga, P. (2019) · Nutrients · doi:10.3390/nu11030507 · Cited by 30
The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL/6N mice
Pan, J. H., Cha, H., Tang, J., Lee, S., Lee, S. H., Le, B., Redding, M. C., Kim, S., Batish, M., Kong, B. C., et al. (2020) · Food & Function · doi:10.1039/d0fo02286a · Cited by 30
Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation
Zhang, J., Powell, C. A., Kay, M., Sonkar, R., Meruvu, S., & Choudhury, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041822 · Cited by 30
Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease
Zaiou, M., Amrani, R., Rihn, B. H., & Hajri, T. (2021) · Biomedicines · doi:10.3390/biomedicines9091256 · Cited by 30
Verbascoside exerts an anti-atherosclerotic effect by regulating liver glycerophospholipid metabolism
Lei, P., Lü, J., Yao, T., Zhang, P., Chai, X., Wang, Y., & Jiang, M. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.035 · Cited by 29
Psoriasis and Nonalcoholic Fatty Liver Disease
Carrascosa, J. M., Bonanad, C., Daudén, E., Botella, R., & Olveira-Martín, A. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2017.05.017 · Cited by 27
Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats
Jeyapal, S., Putcha, U. K., Mullapudi, S. V., Ghosh, S., Sakamuri, A., Kona, S. R., Santosh, V. S., Madakasira, C., & Ibrahim, A. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1492-1 · Cited by 28
Effects of Moringa oleifera Leaves Extract on High Glucose-Induced Metabolic Changes in HepG2 Cells
Gutiérrez, J. A. S., Valdez-Solana, M. A., Forbes-Hernández, T. Y., Avitia-Domínguez, C. I., García-Vargas, G. G., Salas-Pacheco, J. M., Flores-Herrera, Ó., Téllez‐Valencia, A., Battino, M. A., & Sierra‐Campos, E. (2018) · Biology · doi:10.3390/biology7030037 · Cited by 28
Dietary fructose and its association with the metabolic syndrome in Lebanese healthy adults: a cross-sectional study
Aoun, R., Chokor, F. A. Z., Taktouk, M., Nasrallah, M., Isma’eel, H., Tamim, H., & Nasreddine, L. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00800-5 · Cited by 31
Attenuation of hepatic fibrosis by p-Coumaric acid via modulation of NLRP3 inflammasome activation in C57BL/6 mice
Truong, T. M. T., Seo, S. H., Chung, S., & Kang, I. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109204 · Cited by 29
High-carbohydrate and fat diet consumption causes metabolic deterioration, neuronal damage, and loss of recognition memory in rats
Fuentes‐Medel, E., Venegas, B., Muñoz‐Arenas, G., Morán, C., Vázquez‐Roque, R. A., Flores, G., Treviño, S., Díaz, A., & Guevara, J. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102237 · Cited by 30

Authors: Softic, S., Cohen, D. E., & Kahn, C. R.
Affiliations: Boston Children's Hospital (US)
Brigham and Women's Hospital (US)
Joslin Diabetes Center (US)
Corresponding author: Kahn, C. Ronald
ORCID: Softic, Samir
Cohen, David E.
Kahn, C. Ronald
Venue: Digestive Diseases and Sciences
Publisher: Springer Science and Business Media LLC
Published: 2016-02-08
Volume: 61
Issue: 5
Pages: 1282-1293
ISSN: 0163-2116 (ISSN-L)
1573-2568
DOI: 10.1007/s10620-016-4054-0
PMC: PMC4838515
OpenAlex: W2286797029
Cited by: 709
References: 133
Citations by year: 2026: 52 · 2025: 76 · 2024: 88 · 2023: 78 · 2022: 92 · 2021: 79 · 2020: 88 · 2019: 57 · 2018: 44 · 2017: 42 · 2016: 13
FWCI: 7.70
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Digestive Diseases and Sciences (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK031036, R01 DK033201, K12 HD000850, R37 DK048873, R01 DK056626, R01 DK103046)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords: non-alcoholic fatty liver disease, dietary fructose, hepatic de novo lipogenesis, high fructose corn syrup, high-fat diet, sugar-sweetened beverages, insulin resistance, SREBP-1c, endoplasmic reticulum stress, uric acid, mitochondrial fatty acid oxidation, reactive oxygen species, hepatic lipid metabolism, metabolic syndrome
MeSH terms: Diet, Fructose, Humans, Liver, Lipogenesis, Non-alcoholic Fatty Liver Disease, High Fructose Corn Syrup

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks